TABLE 3

Descriptors for the compounds reported by Murakami et al. ( 2000 ) and the observed and predicted (using eq. 3) logPS values


Compound

Mechanism

Vsa_base

TPSA

Log D

Observed Log PS

Predicted Log PS

Fold of Error
Digoxin P-gp 0.00 203.06 -0.30 -4.1 -3.7 3
Hypoxanthine 0.00 69.81 -1.66 -3.4 -3.0 3
Methotrexate 0.00 210.54 -2.79 -4.2 -4.5 2
Phenylalanine Uptake 17.74 63.32 -4.81 -1.3 -2.7 28
Quinidine P-gp 0.00 45.59 0.46 -2.7 -2.2 4
Theophylline 0.00 69.30 -1.11 -2.8 -2.8 1
Valproic acid 0.00 37.30 -1.10 -2.1 -2.5 3
Mannitol 0.00 121.38 -5.80 -4.3 -4.5 2
Sucrose 0.00 189.53 -5.12 -4.8 -4.9 1
Alanine Uptake 17.74 63.32 -6.46 -3.4 -3.2 2
Cyclosporine A P-gp 0.00 278.80 1.06 -1.9 -4.0 120
Glibenclamide 0.00 113.60 2.58 -2.8 -2.2 4
Glucose Uptake 0.00 118.22 -4.30 -2.2 -4.1 83
Iodoantipyrine 0.00 23.55 -0.13 -1.1 -2.1 11
Quinine 0.00 45.59 0.46 -2.6 -2.2 3
Tolbutamide 0.00 75.27 1.12 -2.8 -2.3 4
Vinblastine P-gp 0.00 154.10 2.00 -3.5 -2.7 7
Warfarin 0.00 63.60 -0.67 -2.0 -2.6 4
Cimetidine 17.05 88.89 -1.15 -4.1 -2.0 120
Vincristine P-gp 0.00 171.17 0.61 -3.1 -3.2 1
Thiourea

0.00
84.13
-1.99
-3.5
-3.2
2